Opendata, web and dolomites

EVIDENT

Ebola Virus Disease - correlates of protection, determinants of outcome, and clinical management

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "EVIDENT" data sheet

The following table provides information about the project.

Coordinator
BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN 

Organization address
address: BERNHARD NOCHT STRASSE 74
city: HAMBURG
postcode: 20359
website: www.bni.uni-hamburg.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website http://www.evident-project.eu
 Total cost 1˙759˙325 €
 EC max contribution 1˙759˙325 € (100%)
 Programme 1. H2020-EU.3.1. (SOCIETAL CHALLENGES - Health, demographic change and well-being)
 Code Call H2020-Adhoc-2014-20
 Funding Scheme RIA
 Starting year 2014
 Duration (year-month-day) from 2014-11-01   to  2016-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN DE (HAMBURG) coordinator 481˙660.00
2    Department of Health UK (Leeds) participant 406˙943.00
3    ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO IT (ROMA) participant 226˙465.00
4    EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH DE (ST INGBERT) participant 163˙375.00
5    BUNDESMINISTERIUM DER VERTEIDIGUNG DE (BONN) participant 73˙625.00
6    PHILIPPS UNIVERSITAET MARBURG DE (MARBURG) participant 73˙625.00
7    ROBERT KOCH-INSTITUT DE (Berlin) participant 73˙437.00
8    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) participant 73˙193.00
9    ORSZAGOS EPIDEMIOLOGIAI KOZPONT HU (BUDAPEST) participant 72˙500.00
10    UNIVERZA V LJUBLJANI SI (LJUBLJANA) participant 72˙000.00
11    ARTSEN ZONDER GRENZEN (MEDECINS SANS FRONTIERES NEDERLAND) VERENIGING NL (Amsterdam) participant 42˙500.00

Map

 Project objective

The Ebola virus disease (EVD) epidemic in West Africa is not under control. This proposal has immediate, mid-term and long-term objectives to combat the current and future EVD epidemics. Objectives with immediate impact are: (i) Providing key information needed to implement efficient convalescent plasma treatment and a toolkit to determine the suitability of plasma for treatment; (ii) Providing key information needed to estimate the efficacy of experimental vaccines, including correlates of protection at T cell level; (iii) Improving supportive treatment of patients and reducing hospital case fatality rate by providing information on biomarkers and relevant co-infections; (iv) Monitoring development of mutations in Ebola virus (EBOV) genomes during the epidemic and enhancing our preparedness to determine the relevance of these changes in experimental systems; and (v) Protecting health care workers and communities by providing information on virus shedding in body fluids and estimation of infectiousness in various stages of EVD. Objectives with mid to long-term impact are: (i) Provide information on pathophysiological changes and immunological determinants to infer new immunotherapeutic strategies for treatment of EVD; and (ii) Strengthening cooperation of biosafety level 4 (BSL-4) facilities and building a pan-European research area in the field of highly pathogenic viruses as envisaged in the ‘European Research Infrastructure on Highly Pathogenic Agents’ project. The concept of EVIDENT is to scientifically exploit specimens collected from EVD patients during outbreak response and field research. We will use state-of-the-art methodologies within the EU BSL-4 facilities to gather new and outbreak-relevant knowledge on B and T cell immunology, biomarkers, virus evolution, virulence determinants, and transmission of EBOV. The consortium contributes to the outbreak response since March 2014 and is competent to implement a project in the outbreak area.

 Deliverables

List of deliverables.
External project website Websites, patent fillings, videos etc. 2019-07-25 12:47:38

Take a look to the deliverables list in detail:  detailed list of EVIDENT deliverables.

 Publications

year authors and title journal last update
List of publications.
2015 Vincent Madelain, Lisa Oestereich, Frederik Graw, Thi Huyen Tram Nguyen, Xavier de Lamballerie, France Mentré, Stephan Günther, Jeremie Guedj
Ebola virus dynamics in mice treated with favipiravir
published pages: 70-77, ISSN: 0166-3542, DOI: 10.1016/j.antiviral.2015.08.015
Antiviral Research 123 2019-07-25
2016 Erik Dietzel, Gordian Schudt, Verena Krähling, Mikhail Matrosovich, Stephan Becker
Functional characterization of adaptive mutations during the West African Ebola virus outbreak
published pages: JVI.01913-16, ISSN: 0022-538X, DOI: 10.1128/JVI.01913-16
Journal of Virology 2019-07-25
2016 Séverine Caluwaerts, Tessy Fautsch, Daphne Lagrou, Michel Moreau, Alseny Modet Camara, Stephan Günther, Antonino Di Caro, Benny Borremans, Fara Raymond Koundouno, Joseph Akoi Bore, Christopher H. Logue, Martin Richter, Roman Wölfel, Eeva Kuisma, Andreas Kurth, Stephen Thomas, Gillian Burkhardt, Elin Erland, Fanshen Lionetto, Patricia Lledo Weber, Olimpia de la Rosa, Hassan Macpherson, Michel Va
Dilemmas in Managing Pregnant Women With Ebola: 2 Case Reports: Table 1.
published pages: 903-905, ISSN: 1058-4838, DOI: 10.1093/cid/civ1024
Clinical Infectious Diseases 62/7 2019-07-25
2016 Joshua Quick, Nicholas J. Loman, Sophie Duraffour, Jared T. Simpson, Ettore Severi, Lauren Cowley, Joseph Akoi Bore, Raymond Koundouno, Gytis Dudas, Amy Mikhail, Nobila Ouédraogo, Babak Afrough, Amadou Bah, Jonathan H. J. Baum, Beate Becker-Ziaja, Jan Peter Boettcher, Mar Cabeza-Cabrerizo, Álvaro Camino-Sánchez, Lisa L. Carter, Juliane Doerrbecker, Theresa Enkirch, Isabel García- Dorival, Nico
Real-time, portable genome sequencing for Ebola surveillance
published pages: 228-232, ISSN: 0028-0836, DOI: 10.1038/nature16996
Nature 530/7589 2019-07-25
2016 Toni Rieger, Romy Kerber, Hussein El Halas, Elisa Pallasch, Sophie Duraffour, Stephan Günther, Stephan Ölschläger
Evaluation of RealStar Reverse Transcription–Polymerase Chain Reaction Kits for Filovirus Detection in the Laboratory and Field
published pages: S243-S249, ISSN: 0022-1899, DOI: 10.1093/infdis/jiw246
Journal of Infectious Diseases 214/suppl 3 2019-07-25
2016 Paula Ruibal, Lisa Oestereich, Anja Lüdtke, Beate Becker-Ziaja, David M. Wozniak, Romy Kerber, Miša Korva, Mar Cabeza-Cabrerizo, Joseph A. Bore, Fara Raymond Koundouno, Sophie Duraffour, Romy Weller, Anja Thorenz, Eleonora Cimini, Domenico Viola, Chiara Agrati, Johanna Repits, Babak Afrough, Lauren A. Cowley, Didier Ngabo, Julia Hinzmann, Marc Mertens, Inês Vitoriano, Christopher H. Logue, Jan
Unique human immune signature of Ebola virus disease in Guinea
published pages: 100-104, ISSN: 0028-0836, DOI: 10.1038/nature17949
Nature 533/7601 2019-07-25
2016 Boubacar Diallo, Daouda Sissoko, Nicholas J. Loman, Hadja Aïssatou Bah, Hawa Bah, Mary Claire Worrell, lya Saidou Conde, Ramata Sacko, Samuel Mesfin, Angelo Loua, Jacques Katomba Kalonda, Ngozi A. Erondu, Benjamin A. Dahl, Susann Handrick, Ian Goodfellow, Luke W. Meredith, Matthew Cotten, Umaru Jah, Raoul Emeric Guetiya Wadoum, Pierre Rollin, N\'Faly Magassouba, Denis Malvy, Xavier Anglaret, Miles
Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days
published pages: 1353-1356, ISSN: 1058-4838, DOI: 10.1093/cid/ciw601
Clinical Infectious Diseases 63/10 2019-07-25
2016 Verena Krähling, Dirk Becker, Cornelius Rohde, Markus Eickmann, Yonca Eroğlu, Astrid Herwig, Romy Kerber, Katharina Kowalski, Júlia Vergara-Alert, Stephan Becker
Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus
published pages: 173-183, ISSN: 0300-8584, DOI: 10.1007/s00430-015-0438-6
Medical Microbiology and Immunology 205/2 2019-07-25
2016 Daouda Sissoko, Cedric Laouenan, Elin Folkesson, Abdoul-Bing M’Lebing, Abdoul-Habib Beavogui, Sylvain Baize, Alseny-Modet Camara, Piet Maes, Susan Shepherd, Christine Danel, Sara Carazo, Mamoudou N. Conde, Jean-Luc Gala, Géraldine Colin, Hélène Savini, Joseph Akoi Bore, Frederic Le Marcis, Fara Raymond Koundouno, Frédéric Petitjean, Marie-Claire Lamah, Sandra Diederich, Alexis Tounkara, Gee
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
published pages: e1001967, ISSN: 1549-1676, DOI: 10.1371/journal.pmed.1001967
PLOS Medicine 13/3 2019-07-25
2016 C Agrati, C Castilletti, R Casetti, A Sacchi, L Falasca, F Turchi, N Tumino, V Bordoni, E Cimini, D Viola, E Lalle, L Bordi, S Lanini, F Martini, E Nicastri, N Petrosillo, V Puro, M Piacentini, A Di Caro, G P Kobinger, A Zumla, G Ippolito, M R Capobianchi
Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection
published pages: e2164, ISSN: 2041-4889, DOI: 10.1038/cddis.2016.55
Cell Death and Disease 7/3 2019-07-25
2016 Romy Kerber, Ralf Krumkamp, Boubacar Diallo, Anna Jaeger, Martin Rudolf, Simone Lanini, Joseph Akoi Bore, Fara Raymond Koundouno, Beate Becker-Ziaja, Erna Fleischmann, Kilian Stoecker, Silvia Meschi, Stéphane Mély, Edmund N. C. Newman, Fabrizio Carletti, Jasmine Portmann, Misa Korva, Svenja Wolff, Peter Molkenthin, Zoltan Kis, Anne Kelterbaum, Anne Bocquin, Thomas Strecker, Alexandra Fizet, Conc
Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015
published pages: S250-S257, ISSN: 0022-1899, DOI: 10.1093/infdis/jiw269
Journal of Infectious Diseases 214/suppl 3 2019-07-25
2016 Anja Lüdtke, Paula Ruibal, Beate Becker-Ziaja, Monika Rottstegge, David M. Wozniak, Mar Cabeza-Cabrerizo, Anja Thorenz, Romy Weller, Romy Kerber, Juliana Idoyaga, N\'Faly Magassouba, Martin Gabriel, Stephan Günther, Lisa Oestereich, César Muñoz-Fontela
Ebola Virus Disease Is Characterized by Poor Activation and Reduced Levels of Circulating CD16 + Monocytes
published pages: S275-S280, ISSN: 0022-1899, DOI: 10.1093/infdis/jiw260
Journal of Infectious Diseases 214/suppl 3 2019-07-25
2015 Thomas Strecker, Bernadett Palyi, Heinz Ellerbrok, Sylvie Jonckheere, Hilde de Clerck, Joseph Akoi Bore, Martin Gabriel, Kilian Stoecker, Markus Eickmann, Michel van Herp, Pierre Formenty, Antonino Di Caro, Stephan Becker
Field Evaluation of Capillary Blood Samples as a Collection Specimen for the Rapid Diagnosis of Ebola Virus Infection During an Outbreak Emergency
published pages: 669-675, ISSN: 1058-4838, DOI: 10.1093/cid/civ397
Clinical Infectious Diseases 61/5 2019-07-25
2015 Miles W. Carroll, David A. Matthews, Julian A. Hiscox, Michael J. Elmore, Georgios Pollakis, Andrew Rambaut, Roger Hewson, Isabel García-Dorival, Joseph Akoi Bore, Raymond Koundouno, Saïd Abdellati, Babak Afrough, John Aiyepada, Patience Akhilomen, Danny Asogun, Barry Atkinson, Marlis Badusche, Amadou Bah, Simon Bate, Jan Baumann, Dirk Becker, Beate Becker-Ziaja, Anne Bocquin, Benny Borremans, A
Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa
published pages: 97-101, ISSN: 0028-0836, DOI: 10.1038/nature14594
Nature 524/7563 2019-07-25

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EVIDENT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EVIDENT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.)

BFHA 2020 (2019)

Innovation for better ageing

Read More  

VHFMoDRAD (2019)

Viral Haemorrhagic Fever: Modern Approaches for developing bedside Rapid Diagnostics

Read More  

eHealth Week (2016)

eHealth Week 2016

Read More